CSF3 and infection: Data from individual randomized clinical trials (RCTs) have been supported by results from meta-analyses, which have also demonstrated that G-CSF use reduces the incidence and duration of FN-related hospitalization (Holmes et al. 2002b), as well as the need for antibiotic treatment and the risk of infection-related mortality (Kuderer et al. 2007).